Javascript must be enabled to continue!
MO623: Risk Factors of Diabetic Nephropathy Among Newly Detected Type 2 Diabetic Subjects: Preliminary Report from A Tertiary Care Hospital of Bangladesh
View through CrossRef
Abstract
BACKGROUND AND AIMS
Patients with type 2 diabetes mellitus may present with different macro- and micro-vascular complications including diabetic nephropathy. This preliminary study was designed to evaluate the risk factors for diabetic nephropathy among type 2 diabetic patients at the time of diabetes diagnosis.
METHOD
A case-control study was done at a tertiary care hospital in Dhaka, Bangladesh from January to September 2017. Adult (≥18 years), type 2 diabetic patients, who were detected as diabetic for the first time within the previous 3 months and who tested, at least, two urine samples for urine albumin-to-creatinine ratio (UACR), at least 6 weeks apart, within a 6-month period, were consecutively enrolled for the study. Pregnant ladies, patients with diagnosed kidney disease, patients having features of glomerulonephritis and systemic diseases including systemic lupus erythematosus and vasculitis, history of recent fever, urinary tract infection and menstruation were excluded. Patients having UACR ≥30 mg/g in at least two (out of 3, if tested) samples were taken as cases and those with UACR <30 mg/g were taken as controls. Data were analyzed by statistical package for social sciences (SPSS) version 20.
RESULTS
Total patients were 224 with female predominance (150, 67%). Fifty one (22.8%) patients had diabetic nephropathy (microalbuminuria = 47 and overt proteinuria = 4). Multivariate regression analysis revealed that hypertension {odds ratio (OR) = 3.71 [95% confidence interval (CI) 1.23–4.31], P = 0.003}, smoking [OR = 3.27 (95% CI 2.91–4.79), P = 0.003], family history of diabetes [OR = 2.31 (95% CI 1.84–3.14), P = 0.005] and diabetic nephropathy [OR = 3.34 (95% CI 2.40–4.97), P = 0.001], dyslipidaemia [OR = 2.31 (95% CI 1.98–3.91), P = 0.023], increased body mass index (BMI) [OR = 2.11 (95% CI 1.54–4.87), P = 0.001] and high glycated haemoglobin (HbA1c) [OR 3.21 (95% CI 1.71–5.97), P = 0.034] were significant risk factors for diabetic nephropathy.
CONCLUSION
Almost 23% of type 2 diabetic patients had diabetic nephropathy during diabetes diagnosis in this study and most patients had microalbuminuria. Presence of hypertension, dyslipidaemia, smoking, family history of diabetes and diabetic nephropathy, increased BMI and high HbA1c were significant risk factors for diabetic nephropathy among patients with type 2 diabetes at diagnosis.
Oxford University Press (OUP)
Title: MO623: Risk Factors of Diabetic Nephropathy Among Newly Detected Type 2 Diabetic Subjects: Preliminary Report from A Tertiary Care Hospital of Bangladesh
Description:
Abstract
BACKGROUND AND AIMS
Patients with type 2 diabetes mellitus may present with different macro- and micro-vascular complications including diabetic nephropathy.
This preliminary study was designed to evaluate the risk factors for diabetic nephropathy among type 2 diabetic patients at the time of diabetes diagnosis.
METHOD
A case-control study was done at a tertiary care hospital in Dhaka, Bangladesh from January to September 2017.
Adult (≥18 years), type 2 diabetic patients, who were detected as diabetic for the first time within the previous 3 months and who tested, at least, two urine samples for urine albumin-to-creatinine ratio (UACR), at least 6 weeks apart, within a 6-month period, were consecutively enrolled for the study.
Pregnant ladies, patients with diagnosed kidney disease, patients having features of glomerulonephritis and systemic diseases including systemic lupus erythematosus and vasculitis, history of recent fever, urinary tract infection and menstruation were excluded.
Patients having UACR ≥30 mg/g in at least two (out of 3, if tested) samples were taken as cases and those with UACR <30 mg/g were taken as controls.
Data were analyzed by statistical package for social sciences (SPSS) version 20.
RESULTS
Total patients were 224 with female predominance (150, 67%).
Fifty one (22.
8%) patients had diabetic nephropathy (microalbuminuria = 47 and overt proteinuria = 4).
Multivariate regression analysis revealed that hypertension {odds ratio (OR) = 3.
71 [95% confidence interval (CI) 1.
23–4.
31], P = 0.
003}, smoking [OR = 3.
27 (95% CI 2.
91–4.
79), P = 0.
003], family history of diabetes [OR = 2.
31 (95% CI 1.
84–3.
14), P = 0.
005] and diabetic nephropathy [OR = 3.
34 (95% CI 2.
40–4.
97), P = 0.
001], dyslipidaemia [OR = 2.
31 (95% CI 1.
98–3.
91), P = 0.
023], increased body mass index (BMI) [OR = 2.
11 (95% CI 1.
54–4.
87), P = 0.
001] and high glycated haemoglobin (HbA1c) [OR 3.
21 (95% CI 1.
71–5.
97), P = 0.
034] were significant risk factors for diabetic nephropathy.
CONCLUSION
Almost 23% of type 2 diabetic patients had diabetic nephropathy during diabetes diagnosis in this study and most patients had microalbuminuria.
Presence of hypertension, dyslipidaemia, smoking, family history of diabetes and diabetic nephropathy, increased BMI and high HbA1c were significant risk factors for diabetic nephropathy among patients with type 2 diabetes at diagnosis.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
CD4 and CXCR5 in Patients with Diabetic Nephropathy
CD4 and CXCR5 in Patients with Diabetic Nephropathy
Background: Diabetes is a metabolic condition characterized by hyperglycemia caused by defects in insulin secretion, insulin activity, or both. Diabetic nephropathy (DN) is one of ...
Diabetic Nephropathy: Advancement in Molecular Mechanism, Pathogenesis, and Management by Pharmacotherapeutics and Natural Compounds
Diabetic Nephropathy: Advancement in Molecular Mechanism, Pathogenesis, and Management by Pharmacotherapeutics and Natural Compounds
The primary cause of End-stage Renal Disease (ESRD) and a possible chronic microvascular
consequence of diabetes mellitus is Diabetic Nephropathy (DN). The early stages of diabetic...
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Evolution of Antimicrobial Resistance in Community vs. Hospital-Acquired Infections
Abstract
Introduction
Hospitals are high-risk environments for infections. Despite the global recognition of these pathogens, few studies compare microorganisms from community-acqu...
The Number of Teeth Is Associated with Diabetic Nephropathy
The Number of Teeth Is Associated with Diabetic Nephropathy
Background: Progression of diabetic nephropathy has serious effects on the life expectancy of diabetic patients. Although diagnoses, lifestyle interventions, and treatment of diabe...
Vitamin D deficiency and VDR TaqI polymorphism on diabetic nephropathy risk among type 2 diabetes patients
Vitamin D deficiency and VDR TaqI polymorphism on diabetic nephropathy risk among type 2 diabetes patients
BackgroundMany studies have shown that vitamin D deficiency and vitamin D receptor TaqI gene polymorphisms are associated with susceptibility to diabetic nephropathy in various pop...
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Renal biopsy in diabetic patients: Histopathological and clinical correlations
Introduction: Diabetes is the leading cause of chronic kidney disease and end-stage kidney disease worldwide. A kidney biopsy in a diabetic patient must be considered when non-diab...

